Cadoret-Manier Onaiza 4
4 · IONIS PHARMACEUTICALS INC · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Cadoret-Manier Onaiza
Chief Corp Development Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-01-02+43,200→ 43,200 totalExercise: $52.87From: 2025-01-02Exp: 2034-01-01→ Common Stock (43,200 underlying)
Footnotes (1)
- [F1]Grant on 01/02/2024 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2024. 25% of the shares subject to the option will vest and become exercisable on 01/02/2025. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.